These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 26259932)

  • 21. Annotation on hyponatremia.
    Thomas TH; Morgan DB
    Am Heart J; 1979 Aug; 98(2):268-9. PubMed ID: 110125
    [No Abstract]   [Full Text] [Related]  

  • 22. [Controversies and therapeutic methods in hyponatremia connected with the inappropriate secretion of antidiuretic hormone syndrome].
    Decaux G; Soupart A
    Rev Med Brux; 1994; 15(2):86-91. PubMed ID: 8029578
    [No Abstract]   [Full Text] [Related]  

  • 23. Tolvaptan for hyponatremia.
    Hoorn EJ; Zietse R
    N Engl J Med; 2007 Mar; 356(9):961; author reply 962-3. PubMed ID: 17338052
    [No Abstract]   [Full Text] [Related]  

  • 24. Successful treatment of ifosfamide-induced hyponatremia with AVP receptor antagonist without interruption of hydration for prevention of hemorrhagic cystitis.
    Glezerman IG
    Ann Oncol; 2009 Jul; 20(7):1283-5. PubMed ID: 19542534
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of hyponatremia.
    Lee JJ; Kilonzo K; Nistico A; Yeates K
    CMAJ; 2014 May; 186(8):E281-6. PubMed ID: 24344146
    [No Abstract]   [Full Text] [Related]  

  • 26. Real-life experience of tolvaptan use in the treatment of severe hyponatraemia due to syndrome of inappropriate antidiuretic hormone secretion.
    Tzoulis P; Waung JA; Bagkeris E; Carr H; Khoo B; Cohen M; Bouloux PM
    Clin Endocrinol (Oxf); 2016 Apr; 84(4):620-6. PubMed ID: 26385871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inappropriate secretion of antidiuretic hormone: correction of hyponatremia by expansion of intravascular fluid volume.
    Bear RA; Drummond J; Halperin ML
    Can Med Assoc J; 1982 Feb; 126(3):275-6. PubMed ID: 7059902
    [No Abstract]   [Full Text] [Related]  

  • 28. [Inappropriate ADH secretion syndrome].
    Rodríguez Cuartero A; González Martínez F
    An Med Interna; 1996 Mar; 13(3):127-9. PubMed ID: 8679842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyponatremia in the cancer patient.
    Workeneh BT; Jhaveri KD; Rondon-Berrios H
    Kidney Int; 2020 Oct; 98(4):870-882. PubMed ID: 32497528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tolvaptan for hyponatremia.
    Ozkan C; Kirkpantur A; Arici M
    N Engl J Med; 2007 Mar; 356(9):962; author reply 962-3. PubMed ID: 17338053
    [No Abstract]   [Full Text] [Related]  

  • 31. [Effective demeclocycline therapy in a patient with over-secretion of antidiuretic hormone following head trauma].
    Igaz P; Tóth M; Mezödy M; Gláz E; Pénzes I; Rácz K; Tulassay Z
    Orv Hetil; 1999 Dec; 140(51):2873-5. PubMed ID: 10647278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tolvaptan for hyponatremia.
    Weise WJ; Rimmer JM; Hood VL
    N Engl J Med; 2007 Mar; 356(9):961; author reply 962-3. PubMed ID: 17329708
    [No Abstract]   [Full Text] [Related]  

  • 33. [Diagnostics and new treatment methods of syndrome of inappropriate antidiuretic hormone secretion (SIADH)].
    Trolle C; Rittig S; Frøkjær J; Jørgensen JO
    Ugeskr Laeger; 2012 Apr; 174(15):1019-22. PubMed ID: 22487409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [From hyponatremia to tolvaptan].
    Cernaro V; Santoro D; Lacquaniti A; Montalto G; Buemi M
    G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671837
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The treament of hyponatremia secundary to the syndrome of inappropriate antidiuretic hormone secretion].
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E;
    Med Clin (Barc); 2013 Dec; 141(11):507.e1-507.e10. PubMed ID: 24169317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment with urea as an alternative to tolvaptan for the syndrome of inappropriate secretion of antidiuretic hormone].
    Gómez Valbuena I; Alonso Pérez L; Alioto D; Cañamares Orbis I; Ferrari Piquero JM
    Farm Hosp; 2014 Jul; 38(4):379-80. PubMed ID: 25137170
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Demeclocycline attenuates hyponatremia by reducing aquaporin-2 expression in the renal inner medulla.
    Kortenoeven ML; Sinke AP; Hadrup N; Trimpert C; Wetzels JF; Fenton RA; Deen PM
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1705-18. PubMed ID: 24154696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tolvaptan is successful in treating inappropriate antidiuretic hormone secretion in infants.
    Marx-Berger D; Milford DV; Bandhakavi M; Van't Hoff W; Kleta R; Dattani M; Bockenhauer D
    Acta Paediatr; 2016 Jul; 105(7):e334-7. PubMed ID: 27028950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ten pitfalls in the proper management of patients with hyponatremia.
    Filippatos TD; Liamis G; Elisaf MS
    Postgrad Med; 2016 Jun; 128(5):516-22. PubMed ID: 27153450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
    Nakamura M; Sunagawa O; Kugai T; Kinugawa K
    Int Heart J; 2017 Dec; 58(6):1004-1007. PubMed ID: 29151494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.